Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like Cambridge's Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data January 31, 2017 Varian Inks $50M Multi-Year Project Deal November 5, 2017 Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma August 13, 2017
Cambridge's Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data January 31, 2017
